| P2093 | author name string | Ricardo Titze-de-Almeida | |
| | Simoneide Souza Titze-de-Almeida | |
| | Ana Carolina Martins Domingues | |
| | Camila Hillesheim Horst | |
| | Cínthia Yara da Silva Ribeiro | |
| | Elaine Del Bel Guimarães | |
| | Franciele Schlemmer | |
| | Gabriel Ginani Ferreira | |
| | Natália de Aguiar Montenegro | |
| | Rafael Rocha de Andrade | |
| P2860 | cites work | Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153 | Q24633965 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | The prediagnostic phase of Parkinson's disease | Q26768732 |
| | Involvement of microRNA in microglia-mediated immune response | Q26851399 |
| | Parkinson's disease: animal models and dopaminergic cell vulnerability | Q28080503 |
| | Repression of alpha-synuclein expression and toxicity by microRNA-7. | Q29542272 |
| | Parkinson's disease: mechanisms and models | Q29547424 |
| | Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 |
| | A highly reproducible rotenone model of Parkinson's disease | Q30490799 |
| | Toxin-induced models of Parkinson's disease | Q33844749 |
| | Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration | Q33915341 |
| | Development of microRNA therapeutics is coming of age. | Q33991443 |
| | Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease | Q34049272 |
| | Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. | Q34110230 |
| | The Promise of MicroRNA Replacement Therapy | Q34134295 |
| | MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. | Q34197681 |
| | MicroRNAs in Parkinson's disease. | Q34247027 |
| | MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. | Q34418730 |
| | Description of Parkinson's disease as a clinical syndrome. | Q35170978 |
| | MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death | Q35583229 |
| | Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration | Q35838968 |
| | Pathogenesis of nigral cell death in Parkinson's disease | Q36122869 |
| | Parkinson disease | Q36319286 |
| | Tissue-specific control of brain-enriched miR-7 biogenesis | Q36557067 |
| | MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression. | Q36744745 |
| | MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease | Q36804513 |
| | MicroRNAs in neurodegenerative diseases and their therapeutic potential. | Q37946984 |
| | Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts | Q37955871 |
| | Neuroinflammation in Parkinson's disease. | Q37968058 |
| | miRNA-Based Therapeutic Strategies | Q38092617 |
| | The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future | Q38557032 |
| | MicroRNA-7: A miRNA with expanding roles in development and disease. | Q38627553 |
| | Therapeutic approaches in Parkinson's disease and related disorders | Q38691406 |
| | The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells | Q38713790 |
| | MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression | Q38829042 |
| | MicroRNA-Let-7a regulates the function of microglia in inflammation | Q38848278 |
| | Advances in markers of prodromal Parkinson disease | Q38992302 |
| | Parkinson's: a syndrome rather than a disease? | Q39060020 |
| | The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market | Q39227810 |
| | Old and new challenges in Parkinson's disease therapeutics. | Q39273471 |
| | Relationship of circulatory BDNF with cognitive deficits in people with Parkinson's disease | Q39947360 |
| | Animal models of α-synucleinopathy for Parkinson disease drug development | Q40106906 |
| | MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax and Sirt2 | Q40684945 |
| | MicroRNA-34a upregulation during seizure-induced neuronal death | Q42560262 |
| | Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration | Q42680857 |
| | The ladder rung walking task: a scoring system and its practical application | Q42949417 |
| | MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model | Q45169578 |
| | Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy | Q46354756 |
| | MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease. | Q47102033 |
| | Parkinson's disease - 200 years: the outstanding contribution of "Old Hubert". | Q47224543 |
| | microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches. | Q47564833 |
| | Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease | Q47721166 |
| | Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo | Q47959536 |
| | Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease. | Q48027557 |
| | Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease | Q48171300 |
| | Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats | Q48490989 |
| | Low BDNF is associated with cognitive impairments in patients with Parkinson's disease | Q48704277 |
| | Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease. | Q52598590 |
| | miR-7 Replacement Therapy in Parkinson's Disease | Q64876756 |
| | Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®. | Q64987729 |
| | MicroRNAs in Parkinson's disease | Q88111994 |
| | Let-7a promotes microglia M2 polarization by targeting CKIP-1 following ICH | Q90573454 |
| P433 | issue | 11 | |
| P304 | page(s) | 2132-2140 | |
| P577 | publication date | 2018-09-28 | |
| P1433 | published in | Neurochemical Research | Q15716728 |
| P1476 | title | Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats | |
| P478 | volume | 43 | |